How are APGE straddle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the APGE straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 121.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$118.98 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a APGE straddle?

The breakeven for the APGE straddle priced on this page is roughly $133.48 and $136.53 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current APGE market-implied 1-standard-deviation expected move is approximately 34.78%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current APGE implied volatility affect this straddle?

APGE ATM IV is at 121.30% with IV rank near 30.68%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

APGE Straddle Strategy

APGE (Apogee Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.

APGE (Apogee Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $8.18B, a beta of 0.62 versus the broader market, a 52-week range of 34.34-133.16, average daily share volume of 2.1M, a public-listing history dating back to 2023, approximately 196 full-time employees. These structural characteristics shape how APGE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.62 indicates APGE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a straddle on APGE?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current APGE snapshot

As of June 29, 2026, spot at $132.66, ATM IV 121.30%, IV rank 30.68%, expected move 34.78%. The straddle on APGE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this straddle structure on APGE specifically: APGE IV at 121.30% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 34.78% (roughly $46.13 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated APGE expiries trade a higher absolute premium for lower per-day decay. Position sizing on APGE should anchor to the underlying notional of $132.66 per share and to the trader's directional view on APGE stock.

APGE straddle setup

The APGE straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With APGE near $132.66, the first option leg uses a $135.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed APGE chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 APGE shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$135.00	$0.08
Buy 1	Put	$135.00	$1.45

APGE straddle risk and reward

Net Premium / Debit: -$152.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$118.98
Breakeven(s): $133.48, $136.53
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

APGE straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on APGE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$13,346.50
$29.34	-77.9%	+$10,413.42
$58.67	-55.8%	+$7,480.35
$88.00	-33.7%	+$4,547.27
$117.33	-11.6%	+$1,614.20
$146.66	+10.6%	+$1,013.88
$175.99	+32.7%	+$3,946.95
$205.33	+54.8%	+$6,880.03
$234.66	+76.9%	+$9,813.10
$263.99	+99.0%	+$12,746.18

When traders use straddle on APGE

Straddles on APGE are pure-volatility plays that profit from large moves in either direction; traders typically buy APGE straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

APGE thesis for this straddle

The market-implied 1-standard-deviation range for APGE extends from approximately $86.53 on the downside to $178.79 on the upside. A APGE long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current APGE IV rank near 30.68% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on APGE should anchor more to the directional view and the expected-move geometry. As a Healthcare name, APGE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to APGE-specific events.

APGE straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. APGE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move APGE alongside the broader basket even when APGE-specific fundamentals are unchanged. Always rebuild the position from current APGE chain quotes before placing a trade.

Frequently asked questions

What is a straddle on APGE?: A straddle on APGE is the straddle strategy applied to APGE (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With APGE stock trading near $132.66, the strikes shown on this page are snapped to the nearest listed APGE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are APGE straddle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the APGE straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 121.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$118.98 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a APGE straddle?: The breakeven for the APGE straddle priced on this page is roughly $133.48 and $136.53 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current APGE market-implied 1-standard-deviation expected move is approximately 34.78%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on APGE?: Straddles on APGE are pure-volatility plays that profit from large moves in either direction; traders typically buy APGE straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current APGE implied volatility affect this straddle?: APGE ATM IV is at 121.30% with IV rank near 30.68%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.